HARRISBURG OFFICE:
1300 Linglestown Rd.
Harrisburg, PA 17110
Tel: (717) 238-2000
Fax: (717) 233-3029

LANCASTER OFFICE:
2148 Embassy Dr.
Suite 107
Lancaster, PA 17603
Tel: (717) 431-4000
Fax: (717) 233-3029

CARLISLE OFFICE:
26 State Avenue
Suite 103
Carlisle, PA 17013
Tel: (717) 241-2244
Fax: (717) 233-3029

HANOVER OFFICE: 
217 Frederick St.
Hanover, PA 17331
Tel: (717) 630-8200
Fax: (717) 233-3029

YORK OFFICE:
2550 Kingston Rd.
Suite 220
York, PA 17402
Tel: (717) 845-7800
Fax: (717) 233-3029

Ketek (telithromycin) - FDA warns against possible "severe liver damage after just a few doses." (ketek article by FDA) The lawyers at Handler, Henning & Rosenberg, LLP are here to help you. With offices in Harrisburg, Lancaster, York, Hanover and Carlisle to help you with your case if you are experiencing any side effects after taking the drug Ketek.

As attorneys for drug related injuries from Ketek, we are here to help and our offices are close to you if you live in the Harrisburg, Lancaster, York, Hanover and Carlisle area.  If you have taken Ketek, there is a possibility of severe side effects that may cause severe liver damage from the use of Ketek.

Ketek Linked to Serious Liver Damage

Concerned with the side effects and possible liver damage from Ketek, we are a Pennsylvania law firm with an expansive team of legal professionals to help you with your case. Our winning team of attorneys handle all areas of accident injury, medical malpractice, defective products, birth injuries, trucking accidents and Ketek cases in the Pennsylvania area.

Ketek Liver Damage Revealed to FDA

Ketek was reported in an article in The Wall Street Journal who uncovered a confidential memo between the FDA and Ketek which revealed twelve that there were several cases of liver failure including four deaths associated with antibiotic medication Ketek (generic: telithromycin).

Although the FDA is not releasing the memo publicly, this has raised new concerns about liver risks in conjunction with Ketek. The FDA has now requested that a stronger warning be placed on Ketek’s label.

Ketek was formally approved by the FDA on April 1st, 2004, but not until two previous application rejections in 2001 and 2003. Ketek, a ketolide antibiotic, was designed for the treatment of respiratory infections including sinusitis, bronchitis, and pneumonia.

Ketek and Liver Toxicity

Three cases of liver toxicity in patients taking Ketek were reported in January 2006 to Dr. John Hanson, who works in the liver transplant center at Carolinas Medical Center. One took Ketek for only five days and ultimately died from liver failure. Another underwent a liver transplant, and the third eventually recovered from hepatitis.

Get Help Now for Ketek Liver Damage Victims